EAM
Eventide Asset Management Portfolio holdings
AUM
$5.71B
This Quarter Return
+2.92%
1 Year Return
+51.18%
3 Year Return
+209.28%
5 Year Return
+283.63%
10 Year Return
+1,480.39%
AUM
$7.56B
AUM Growth
+$7.56B
(+1.6%)
Cap. Flow
+$133M
Cap. Flow
% of AUM
1.75%
Top 10 Holdings %
Top 10 Hldgs %
25.56%
Holding
165
New
13
Increased
52
Reduced
26
Closed
13
Top Buys
| 1 |
DICE
DICE Therapeutics, Inc. Common Stock
DICE
|
$59.2M |
| 2 |
FIVE9
FIVN
|
$46.1M |
| 3 |
Xometry
XMTR
|
$42M |
| 4 |
Global E Online
GLBE
|
$34.3M |
| 5 |
Fiverr
FVRR
|
$28.7M |
Top Sells
| 1 |
BHVN
Biohaven Pharmaceutical Holding Company Ltd.
BHVN
|
$92.5M |
| 2 |
TRIL
Trillium Therapeutics Inc.
TRIL
|
$75.2M |
| 3 |
Celldex Therapeutics
CLDX
|
$53M |
| 4 |
BridgeBio Pharma
BBIO
|
$43.4M |
| 5 |
RingCentral
RNG
|
$33.8M |
Sector Composition
| 1 | Healthcare | 34.45% |
| 2 | Technology | 30.19% |
| 3 | Industrials | 13.01% |
| 4 | Consumer Discretionary | 7.21% |
| 5 | Communication Services | 4.52% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Shares Change % | Capital Flow | |
|---|---|---|---|---|---|---|
26
Waste Connections
WCN
$46.5B
| $101M | 1.34% |
804,000
| – | – |
|
27
argenx
ARGX
$44.2B
| $101M | 1.33% |
333,000
| – | – |
|
|
TRIL
28
DELISTED
Trillium Therapeutics Inc.
TRIL
| $91.8M | 1.21% |
5,227,376
-4,282,624
| -45% | -$75.2M |
|
|
KRTX
29
DELISTED
Karuna Therapeutics, Inc. Common Stock
KRTX
| $91.5M | 1.21% |
748,000
| – | – |
|
30
Trex
TREX
$6.41B
| $89.9M | 1.19% |
882,000
| – | – |
|
31
Entegris
ENTG
$12B
| $89.4M | 1.18% |
709,999
+58,400
| +9% | +$7.35M |
|
32
D.R. Horton
DHI
$51.3B
| $88.6M | 1.17% |
1,055,493
| – | – |
|
33
Wayfair
W
$10.3B
| $85.5M | 1.13% |
334,477
+915
| +0.3% | +$234K |
|
|
RXDX
34
DELISTED
Prometheus Biosciences, Inc. Common Stock
RXDX
| $85.1M | 1.12% |
3,714,032
| – | – |
|
35
Aptiv
APTV
$17.3B
| $80M | 1.05% |
537,000
| – | – |
|
36
Palo Alto Networks
PANW
$128B
| $72.8M | 0.96% |
911,922
+15,900
| +2% | +$1.27M |
|
37
Praxis Precision Medicines
PRAX
$980M
| $70.5M | 0.93% |
254,040
+1,570
| +0.6% | +$435K |
|
38
Datadog
DDOG
$46.2B
| $68.6M | 0.9% |
485,104
| – | – |
|
|
ALLK
39
DELISTED
Allakos
ALLK
| $66.7M | 0.88% |
630,000
+229,000
| +57% | +$24.2M |
|
|
40
Celldex Therapeutics
CLDX
$1.57B
| $60.9M | 0.8% |
1,128,000
-980,908
| -47% | -$53M |
|
|
DICE
41
DELISTED
DICE Therapeutics, Inc. Common Stock
DICE
| $59.2M | 0.78% |
+1,871,612
| New | +$59.2M |
|
42
Yeti Holdings
YETI
$2.84B
| $59.1M | 0.78% |
690,000
| – | – |
|
43
Magna International
MGA
$12.7B
| $58.7M | 0.77% |
780,000
-35,600
| -4% | -$2.68M |
|
44
Crown Castle
CCI
$42.3B
| $56.8M | 0.75% |
327,700
+14,600
| +5% | +$2.53M |
|
45
Shoals Technologies Group
SHLS
$1.13B
| $53.1M | 0.7% |
1,905,060
+457,600
| +32% | +$12.8M |
|
46
Collegium Pharmaceutical
COLL
$1.25B
| $51.9M | 0.68% |
2,629,593
| – | – |
|
47
Vital Farms
VITL
$2.2B
| $51.8M | 0.68% |
2,950,000
-58,232
| -2% | -$1.02M |
|
48
Hannon Armstrong Sustainable Infrastructure Capital
HASI
$3.46B
| $51.6M | 0.68% |
964,000
+263,800
| +38% | +$14.1M |
|
49
Agilent Technologies
A
$35.5B
| $50.8M | 0.67% |
322,300
+170,600
| +112% | +$26.9M |
|
50
TSMC
TSM
$1.2T
| $50.6M | 0.67% |
453,100
| – | – |
|